HEALTHIER
By Choice
Holistic Health Recovery
Physical, Mental & Emotional Wellness Support
Cardiovascular
Health
for a long and vibrant life
Cardiovascular Disease (CVD)
Being one of the leading causes of death worldwide, Cardiovascular disease steals more years of potential life than any other human condition. Fortunately, over the past thirty years significant progress has been made in the areas of diagnosis, prevention and treatment of CVD. One of the most critical advances has been the identification of the major risk factors for CVD which arose from studies such as the Framingham Heart Study and the Seven Countries Study.
Conventional risk factors for CVD include hypertension, smoking, diabetes, central obesity, high cholesterol, and low HDL cholesterol. However, in an individual the presence of only one of these factors has a low positive predictive value, with a significant number of cardiovascular events still occurring in individuals without these risk indicators being present.
Without a doubt, diet and lifestyle factors can hinder or enhance heart and vascular health. Evaluating risk preventatively can be one of the most valuable preventative things a person can do, particularly from the age of 40 on.
Research
With a significant amount of research in recent years on cardiovascular disease, which is a group of conditions that affect the heart and blood vessels, including coronary artery disease, heart failure, and stroke. Here are some recent findings:
-
Role of inflammation: Inflammation is thought to play a key role in the development of cardiovascular disease, and getting to the cause of chronic inflammation in the body is important to reduce the risk of heart attack and stroke in those who are vulnerable to these conditions.
-
Genetic factors: Recent research has identified several genetic factors that may contribute to the development of cardiovascular disease. For example, a study published in Nature Genetics in 2020 identified 14 new genetic variants associated with heart disease risk. Having a Comprehensive Genetic Profile Panel done helps bring to awareness your underlying risk factors, if present.
-
Lifestyle factors: Lifestyle factors such as diet, exercise, and smoking are important modifiable risk factors for cardiovascular disease. Recent research has focused on the role of plant-based diets in reducing the risk of heart disease, as well as the potential benefits of high-intensity interval training (HIIT) for improving cardiovascular health.
-
Novel therapies: There have been several new therapies developed in recent years for the treatment of cardiovascular disease. For example, PCSK9 inhibitors, a class of medications that lower LDL cholesterol, have been shown to reduce the risk of cardiovascular events in people with a history of heart disease. Additionally, gene therapy and stem cell therapy are being explored as potential treatments for heart failure.
-
COVID-19 and cardiovascular disease: There is growing evidence that COVID-19 can have a significant impact on the cardiovascular system, with studies suggesting that the virus can cause inflammation and damage to the heart muscle. Additionally, people with pre-existing cardiovascular disease may be at higher risk of severe illness and death from COVID-19. (*Research paper links below)
-
Covid Vaccines: On the government website as at 1.5.23, it states "The risk of myocarditis is higher (although still rare) after vaccination with Moderna original formulation compared with Pfizer original formulation." and "Evidence suggests that AstraZeneca and Novavax are probably associated with a small increased risk of myocarditis and pericarditis." I personally have had clients who have taken these vaccines report to their GP with an increased clotting risk, and one of my patients had a stroke after it. The Astrazenica vaccine was quietly pulled from the Australian market as at March 20th 2023, and interestingly Pfeizer is under investigation in America for it's link with increased cardiovascular risk. It is too early for all the research to be in, but it is an important space to be alert to if you have taken any of the vaccines under investigation.
Cholesterol
SAying that cholesterol causes cardiovascular disease is like saying fire engines cause fires. It is ludicrous and ignores the important role cholesterol plays in managing inflammation and other factors responsible for vascular health.
Functional Lab Testing
Blood testing of cholesterol through the doctor doesn't give us the detailed information we need to evaluate cholesterol and cardiovascular risk. There is so much more to cholesterol than we can see on a standard blood test. These two profiling reports give us so much more information from which to work.
Cholesterol Subfractions (4028)
Cholesterol is a far more complex substance than we are led to believe. Having high cholesterol is not a statin deficiency, it is caused by a number of things, and they aren't all bad.
Cholesterol is a healing substance. It is only a problem when it is oxidised, or small and dense. A cholesterol test from the doctor that doesn't look at subfractions of cholesterol is inadequate to determine risk.
This Liposcreen separates and quantifies all lipoprotein sub-fractions including the ‘large’, less atherogenic LDL-1 and LDL-2 and the ‘small’, highly atherogenic LDL-3 to LDL-7. The test also measures VLDL and IDL cholesterol linked with type III dyslipidaemia and associated hyperlipoproteinaemias.
Approximately 50% of patients without heart attack have higher cholesterol levels. A considerable portion of heart attack patients have low cholesterol levels.
Individual differences exist in particular with respect to the LDL levels and here, even more importantly, in the size distribution of the LDL particles. The small LDL particles in particular have a very high atherogenic potential. Therefore, it is less important how much cholesterol a patient has but which type of cholesterol is elevated and which size distribution the cholesterol particles have. These are the parameters the risk assessment and therapy depend on.
-
Cholesterol
-
Triglycerides
-
HDL - High Density Lipoprotein
-
LDL - Low Density Lipoprotein
-
VLDL - Very Low Density Lipoprotein
-
IDL -
-
LDL subfractions (x7)
-
Particle Size
Cardiovascular Profile Comprehensive 2 (4027)
At present, the most advanced strategy for coronary risk assessment is therefore to combine the information of several risk factors. This multi-marker approach can enhance risk stratification, identifying those individuals with a moderate baseline risk who might benefit from aggressive risk reduction strategies. Not only are conventional risk factors assessed, but other CVD biomarkers such as lipoprotein (a), apolipoproteins A & B, homocysteine, fibrinogen and C-reactive protein (CRP) are included.
The Comprehensive 2 option for the Cardiovascular Profile includes Liposcreen LDL-Subfraction analytes. Liposcreen separates and quantifies all lipoprotein sub-fractions including the ‘large’, less atherogenic LDL-1 and LDL-2 and the ‘small’, highly atherogenic LDL-3 to LDL-7. The test also measures VLDL and IDL cholesterol linked with type III dyslipidaemia and associated hyperlipoproteinaemias.
Common related conditions:
-
Hypercholesterolemia
-
Insulin resistance
-
Diabetes
-
Cardiovascular disease
-
Statin therapy
Tested :
-
Triglycerides
-
HDL
-
LDL
-
ratios
-
VLDL
-
IDL
-
LDL Subfractions (x7)
-
Fasting Glucose
-
Lipoprotein (a)
-
Apolipoproteins A & B
-
Homocysteine
-
Fibrinogen
-
C-reactive protein (CRP).
Personalised Health Care
Each person is an individual, with their own unique lifestyle factors and needs. We treat each person as an individual, looking at causative drivers, nutritional factors, food intolerances and medical tests, to help find the best way forward for you.
Call to discuss your needs today.
* Research papers from item 5 above:
-
Cardiovascular implications of COVID-19 infections: A comprehensive review - https://www.amjmed.com/article/S0002-9343(20)30673-2/fulltext
-
COVID-19 and the cardiovascular system - https://www.nature.com/articles/s41569-020-0360-5
-
Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China - https://jamanetwork.com/journals/jamacardiology/fullarticle/2763845
-
Cardiovascular risk factors and COVID-19 outcomes - https://www.thelancet.com/journals/landia/article/PIIS2213-8587(20)30264-3/fulltext
-
COVID-19 and cardiovascular disease: From bench to bedside - https://academic.oup.com/cardiovascres/article/116/14/e166/5844224